MicroTISSUE: pathology-specific drug screening
MicroTISSUE dissects cell-cell contribution in complex pathologies.
It is used in several complex drug screening screening programs (cancer, neurodegenerative diseases, autoimmune diseases, cardiovascular, skin and ophthalmic diseases).
MicroTISSUE generates rapid and informative data on efficacy, toxicity, metabolism and compound-receptor binding effects as well as understanding of molecular mechanisms associated with response to candidate drugs.
Moreover, it enables effective selection and ranking of the most promising candidates per indication